Reports that an Indian university will begin teaching doctors how to treat people possessed by ghosts appear to be based on a misunderstanding.
Reports that an Indian university is set to offer a course teaching doctors how to treat people who believe they are possessed by ghosts appear to be based on a misunderstanding.
However, rather than tackling spirit possession, the course is intended to treat psychosomatic or psychological disorders using the traditional Indian medicine system Ayurveda. The quote suggests that the university will be training doctors how to treat people for illnesses caused by ghosts, but this appears to be based on a contextual misunderstanding of the word"bhoot." Although the word can be translated as"ghost," in Ayurvedic medicine the word is said to actually refer to anything small enough that it can't be seen. A further IANS quote clarified that the course focuses on"diseases of the mind.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Singapore police probe Indian for alleged Modi citizenship law protestSingapore police are investigating an Indian national for allegedly being involv...
Consulte Mais informação »
Indian IPOs fall to four-year low as economy faltersIndian initial public offerings tumbled to a 4-year low by value in 2019 as the ...
Consulte Mais informação »
Indian state demands damages, threatens to confiscate property over protestsIndia's northern Uttar Pradesh state is demanding millions of rupees from o...
Consulte Mais informação »
15 years since the Indian Ocean tsunami | Pictures | Reuters(Warning: graphic content) An Indian woman mourns the death of her relative (R) who was killed a tsunami in Cuddalore, India December 28, 2004. December 26 marks 15 years since a 9.1 magnitude quake o
Consulte Mais informação »
1st monthly HIV drug doesn't receive FDA approvalOn Saturday, the Food and Drug Administrations declined the approval of the much anticipated Cabenuva, the first long acting HIV drug.
Consulte Mais informação »